Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment.

MLA

Pretta, Andrea, et al. “Influence of Antidiabetic Drugs on Glucose Metabolism and Immune Response in Patients with Metastatic Pancreatic Ductal Adenocarcinoma Receiving Gemcitabine plus Nab-Paclitaxel as First-Line Treatment.” Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, vol. 55, no. 5, May 2023, pp. 655–60. EBSCOhost, https://doi.org/10.1016/j.dld.2022.11.012.

APA

Pretta, A., Ziranu, P., Giampieri, R., Donisi, C., Cimbro, E., Spanu, D., Lai, E., Pecci, F., Balconi, F., Lupi, A., Pozzari, M., Persano, M., Murgia, S., Pusceddu, V., Puzzoni, M., Berardi, R., & Scartozzi, M. (2023). Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 55(5), 655–660. https://doi.org/10.1016/j.dld.2022.11.012

Chicago

Pretta, Andrea, Pina Ziranu, Riccardo Giampieri, Clelia Donisi, Erika Cimbro, Dario Spanu, Eleonora Lai, et al. 2023. “Influence of Antidiabetic Drugs on Glucose Metabolism and Immune Response in Patients with Metastatic Pancreatic Ductal Adenocarcinoma Receiving Gemcitabine plus Nab-Paclitaxel as First-Line Treatment.” Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 55 (5): 655–60. doi:10.1016/j.dld.2022.11.012.